Meniere's attacks occur in the inner ear with excessive vasopressin type-2 receptors

Journal of Neuroendocrinology

Volumn 20, Issue 12, 2008, Pages 1295-1300

  Kitahara, Todoshi ^a   Doi, K ^a   Maekawa, C ^a   Kizawa, K ^a   Horii, A ^a   Kubo, T ^a   Kiyama, H ^b  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b School of Medicine   (Japan)

Author keywords

cAMP; Inner ear; Meniere's disease; Stress hormone; V2 receptor; Vasopressin

Indexed keywords

CYCLIC AMP; MESSENGER RNA; VASOPRESSIN V2 RECEPTOR;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ENDOLYMPHATIC SAC; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; HISTOPATHOLOGY; HOMEOSTASIS; HORMONE RESPONSE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MENIERE DISEASE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR UPREGULATION; STRESS;

ANIMALS; CYCLIC AMP; EAR, INNER; FEMALE; HUMANS; MALE; MENIERE DISEASE; NEUROMA, ACOUSTIC; RECEPTORS, VASOPRESSIN; VASOPRESSINS;

EID: 56649124839     PISSN: 09538194     EISSN: 13652826     Source Type: Journal    
DOI: 10.1111/j.1365-2826.2008.01792.x     Document Type: Article

References (24)

1. Yamakawa K. Uber die pathologische Veranderung bei einem Meniere-Kranken. J Otolaryngol Jpn 1938; 44: 2310-2312.
2. Hallpike CS, Cairns H. Observations on the pathology of Meniere's syndrome. J Laryngol Otol 1938; 53: 625-655.
3. Ishiyama G, Lopez IA, Ishiyama A. Aquaporins and Meniere's disease (review). Curr Opin Otolaryngol Head Neck Surg 2006; 14: 332-336.
4. Committee on hearing and equilibrium. Committee on hearing and equilibrium guidelines for diagnosis and evaluation of therapy in Meniere's disease. Otolaryngol Head Neck Surg 1995; 113: 181-185.
5. Claes J, Van de Heyning PH. A review of medical treatment for Meniere's disease. Acta Otolaryngologica Suppl 2000; 544: 34-39.
6. Kitahara T, Takeda N, Mishiro Y, Saika T, Fukushima M, Okumura S, Kubo T. Effects of exposing the opened endolymphatic sac to large doses of steroids to treat intractable Meniere's disease. Ann Otol Rhinol Laryngol 2001; 110: 109-112.
7. Kitahara T, Kondoh K, Morihana T, Okumura S, Mishiro Y, Kubo T. Surgical management for special cases of intractable Meniere's disease: unilateral cases with intact canals and bilateral cases. Ann Otol Rhinol Laryngol 2004; 113: 399-403.
8. Kitahara T, Kubo T, Okumura S, Kitahara M. Effects of endolymphatic sac drainage with steroids for intractable Meniere's disease: A long-term follow-up and randomized controlled study. Laryngoscope 2008; 118: 854-861.
9. Aoki M, Asai M, Nishihori T, Mizuta K, Ito Y, Ando K. The relevance of an elevation in the plasma vasopressin levels to the pathogenesis of Meniere's attack. J Neuroendocrinol 2007; 19: 901-906.
10. Schmittgen TD, Zakrajsek BA, Mills AG, Gorn V, Singer MJ, Reed MW. Quantitative reverse transcription polymerase chain reaction to study mRNA decay: Comparison of endpoint and real-time methods. Anal Biochem 2000; 285: 194-204.
11. Kumagami H, Loewenheim H, Beitz E, Wild K, Schwartz H, Yamashita K, Schultz J, Paysan J, Zenner HP, Ruppersberg JP. The effect of anti-diuretic hormone on the endolymphatic sac of the inner ear. Pflugers Arch 1998; 436: 970-975.
12. Takeda T, Kakigi A, Saito H. Antidiuretic hormone (ADH) and endolymphatic hydrops. Acta Otolaryngol Suppl 1995; 519: 219-222.
13. Takeda T, Takeda S, Kitano H, Okada T, Kakigi A. Endolymphatic hydrops induced by chronic administration of vasopressin. Hear Res 2000; 140: 1-6.
14. Lim JS, Lange ME, Megerian CA. Serum antidiuretic hormone levels in patients with unilateral Meniere's disease. Laryngoscope 2003; 113: 1321-1326.
15. Yazawa Y, Kitahara M. Bilateral endolymphatic hydrops in Menière's disease: Review of temporal bone autopsies. Ann Otol Rhinol Laryngol 1990; 99: 524-528.
16. Kitano H, Suzuki M, Kitanishi T, Yazawa Y, Kitajima K, Isono T, Takeda T, Kimura H, Tooyama I. Regulation of inner ear fluid in the rat by vasopressin. Neuroreport 1999; 10: 1205-1207.
17. Taguchi D, Takeda T, Kakigi A, Takumida M, Nishioka R, Kitano H. Expressions of aquaporin-2, vasopressin type 2 receptor, transient receptor potential channel vanilloid (TRPV)1, and TRPV4 in the human endolymphatic sac. Laryngoscope 2007; 117: 695-698.
18. Shambaugh GE Jr, Clemis JD, Arenberg IK. Endolymphatic duct and sac in Meniere's disease. I. Surgical and histopathologic observations. Arch Otolaryngol 1969; 89: 816-825.
19. Gutierrez F, Moreno PM, Sainz M. Relationship between immune complex and total hemolytic complement in endolymphatic hydrops. Laryngoscope 1994; 104: 1495-1498.
20. Hughes GB, Kinney SE, Barna BP, Calabrese LH. Autoimmune reactivity in Meniere's disease: A preliminary report. Laryngoscope 1983; 93: 410-417.
21. Yamanobe S, Harris JP. Inner ear-specific autoantibodies. Laryngoscope 1993; 103: 319-325.
22. Yazawa Y, Suzuki M, Hanamitsu M, Kimura H, Tooyama I. Detection of viral DNA in the endolymphatic sac in Ménière's disease by in situ hybridisation. ORL J Otorhinolaryngol Relat Spec 2003; 65: 162-168.
23. Selmani Z, Marttila T, Pyykkö I. Incidence of virus infection as a cause of Meniere's disease or endolymphatic hydrops assessed by electrocochleography. Eur Arch Otorhinolaryngol 2005; 262: 331-334.
24. Schuknecht HF. Pathophysiology of endolymphatic hydrops. Arch Otorhinolaryngol 1976; 212: 253-262.